CA2752247A1 - Dispositifs, procedes et processus permettant de trier des particules et d'obtenir du sperme animal produisant une progeniture de sexe donne - Google Patents
Dispositifs, procedes et processus permettant de trier des particules et d'obtenir du sperme animal produisant une progeniture de sexe donne Download PDFInfo
- Publication number
- CA2752247A1 CA2752247A1 CA2752247A CA2752247A CA2752247A1 CA 2752247 A1 CA2752247 A1 CA 2752247A1 CA 2752247 A CA2752247 A CA 2752247A CA 2752247 A CA2752247 A CA 2752247A CA 2752247 A1 CA2752247 A1 CA 2752247A1
- Authority
- CA
- Canada
- Prior art keywords
- nozzle
- cells
- sperm
- stream
- pulse
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims description 606
- 241001465754 Metazoa Species 0.000 title claims description 38
- 239000002245 particle Substances 0.000 title description 1208
- 210000004027 cell Anatomy 0.000 claims abstract description 1344
- 239000012530 fluid Substances 0.000 claims abstract description 870
- 238000000684 flow cytometry Methods 0.000 claims abstract description 306
- 210000000349 chromosome Anatomy 0.000 claims abstract description 20
- 230000005670 electromagnetic radiation Effects 0.000 claims description 71
- 230000004323 axial length Effects 0.000 claims description 16
- 239000013611 chromosomal DNA Substances 0.000 claims description 16
- 239000011248 coating agent Substances 0.000 claims description 6
- 238000000576 coating method Methods 0.000 claims description 6
- 239000000523 sample Substances 0.000 description 240
- 238000012384 transportation and delivery Methods 0.000 description 200
- 230000006870 function Effects 0.000 description 183
- 238000010186 staining Methods 0.000 description 121
- 239000000203 mixture Substances 0.000 description 110
- 230000008569 process Effects 0.000 description 102
- 238000005286 illumination Methods 0.000 description 101
- 210000000582 semen Anatomy 0.000 description 94
- 238000001816 cooling Methods 0.000 description 75
- 239000000872 buffer Substances 0.000 description 71
- 238000012545 processing Methods 0.000 description 68
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 68
- 230000004899 motility Effects 0.000 description 67
- 229910001868 water Inorganic materials 0.000 description 66
- 239000000725 suspension Substances 0.000 description 64
- 238000001514 detection method Methods 0.000 description 60
- 239000002577 cryoprotective agent Substances 0.000 description 58
- 108090000623 proteins and genes Proteins 0.000 description 53
- 102000004169 proteins and genes Human genes 0.000 description 52
- 239000010902 straw Substances 0.000 description 52
- 239000000975 dye Substances 0.000 description 50
- 238000001914 filtration Methods 0.000 description 46
- 238000007600 charging Methods 0.000 description 45
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 42
- 238000005138 cryopreservation Methods 0.000 description 41
- 230000007423 decrease Effects 0.000 description 41
- 210000004940 nucleus Anatomy 0.000 description 41
- 238000005070 sampling Methods 0.000 description 41
- 239000002699 waste material Substances 0.000 description 40
- 241000283690 Bos taurus Species 0.000 description 39
- 210000001766 X chromosome Anatomy 0.000 description 39
- PRDFBSVERLRRMY-UHFFFAOYSA-N 2'-(4-ethoxyphenyl)-5-(4-methylpiperazin-1-yl)-2,5'-bibenzimidazole Chemical compound C1=CC(OCC)=CC=C1C1=NC2=CC=C(C=3NC4=CC(=CC=C4N=3)N3CCN(C)CC3)C=C2N1 PRDFBSVERLRRMY-UHFFFAOYSA-N 0.000 description 38
- 238000010586 diagram Methods 0.000 description 38
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 36
- 230000008832 photodamage Effects 0.000 description 36
- 238000011084 recovery Methods 0.000 description 35
- 238000012360 testing method Methods 0.000 description 35
- 238000005119 centrifugation Methods 0.000 description 34
- 238000011144 upstream manufacturing Methods 0.000 description 34
- 238000011217 control strategy Methods 0.000 description 33
- 108010000912 Egg Proteins Proteins 0.000 description 32
- 102000002322 Egg Proteins Human genes 0.000 description 32
- 210000002969 egg yolk Anatomy 0.000 description 32
- 235000013345 egg yolk Nutrition 0.000 description 32
- 238000004422 calculation algorithm Methods 0.000 description 31
- 238000004163 cytometry Methods 0.000 description 31
- 210000002593 Y chromosome Anatomy 0.000 description 30
- 239000000654 additive Substances 0.000 description 29
- 238000004458 analytical method Methods 0.000 description 29
- 230000003287 optical effect Effects 0.000 description 29
- 239000000243 solution Substances 0.000 description 29
- 230000003247 decreasing effect Effects 0.000 description 28
- 238000009826 distribution Methods 0.000 description 28
- 239000008366 buffered solution Substances 0.000 description 27
- 239000000463 material Substances 0.000 description 27
- 230000015572 biosynthetic process Effects 0.000 description 26
- 239000008188 pellet Substances 0.000 description 26
- 230000008901 benefit Effects 0.000 description 25
- 238000000605 extraction Methods 0.000 description 25
- 239000006228 supernatant Substances 0.000 description 25
- 230000008859 change Effects 0.000 description 23
- 239000007789 gas Substances 0.000 description 23
- 230000009027 insemination Effects 0.000 description 23
- 244000309464 bull Species 0.000 description 22
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 20
- 229940098773 bovine serum albumin Drugs 0.000 description 20
- 238000002474 experimental method Methods 0.000 description 20
- 239000007788 liquid Substances 0.000 description 20
- 239000002953 phosphate buffered saline Substances 0.000 description 19
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 18
- 230000009021 linear effect Effects 0.000 description 18
- 229910052757 nitrogen Inorganic materials 0.000 description 18
- 238000013459 approach Methods 0.000 description 17
- 239000000284 extract Substances 0.000 description 17
- 235000013336 milk Nutrition 0.000 description 17
- 239000008267 milk Substances 0.000 description 17
- 210000004080 milk Anatomy 0.000 description 17
- 230000035899 viability Effects 0.000 description 17
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 16
- 239000007853 buffer solution Substances 0.000 description 16
- 230000006872 improvement Effects 0.000 description 16
- 230000000750 progressive effect Effects 0.000 description 16
- 229940076788 pyruvate Drugs 0.000 description 16
- 238000000926 separation method Methods 0.000 description 16
- 230000019100 sperm motility Effects 0.000 description 16
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 16
- 239000003242 anti bacterial agent Substances 0.000 description 15
- 230000006378 damage Effects 0.000 description 15
- 238000010790 dilution Methods 0.000 description 15
- 239000012895 dilution Substances 0.000 description 15
- 238000005516 engineering process Methods 0.000 description 15
- 238000004891 communication Methods 0.000 description 14
- 238000011109 contamination Methods 0.000 description 14
- 230000000694 effects Effects 0.000 description 14
- 230000033001 locomotion Effects 0.000 description 14
- 230000007246 mechanism Effects 0.000 description 14
- 239000004606 Fillers/Extenders Substances 0.000 description 13
- 238000005520 cutting process Methods 0.000 description 13
- 238000005259 measurement Methods 0.000 description 13
- 239000013598 vector Substances 0.000 description 13
- 230000002759 chromosomal effect Effects 0.000 description 12
- 230000036541 health Effects 0.000 description 12
- 238000004519 manufacturing process Methods 0.000 description 12
- 238000003908 quality control method Methods 0.000 description 12
- 230000035939 shock Effects 0.000 description 12
- 238000011156 evaluation Methods 0.000 description 11
- 230000003647 oxidation Effects 0.000 description 11
- 238000007254 oxidation reaction Methods 0.000 description 11
- 230000010287 polarization Effects 0.000 description 11
- 238000006722 reduction reaction Methods 0.000 description 11
- 238000004781 supercooling Methods 0.000 description 11
- 230000005284 excitation Effects 0.000 description 10
- 239000000835 fiber Substances 0.000 description 10
- 239000003112 inhibitor Substances 0.000 description 10
- 241000124008 Mammalia Species 0.000 description 9
- 230000003115 biocidal effect Effects 0.000 description 9
- 238000004140 cleaning Methods 0.000 description 9
- 239000012595 freezing medium Substances 0.000 description 9
- 239000002609 medium Substances 0.000 description 9
- 239000012528 membrane Substances 0.000 description 9
- 239000011736 potassium bicarbonate Substances 0.000 description 9
- 235000015497 potassium bicarbonate Nutrition 0.000 description 9
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 9
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 9
- 235000017557 sodium bicarbonate Nutrition 0.000 description 9
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 8
- 108010073771 Soybean Proteins Proteins 0.000 description 8
- 238000012937 correction Methods 0.000 description 8
- 230000003993 interaction Effects 0.000 description 8
- 239000007787 solid Substances 0.000 description 8
- 229940001941 soy protein Drugs 0.000 description 8
- 238000003860 storage Methods 0.000 description 8
- -1 2-hydroxy-1,1-bis[hydroxymethyl] ethyl Chemical group 0.000 description 7
- 108010077544 Chromatin Proteins 0.000 description 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 7
- 229930091371 Fructose Natural products 0.000 description 7
- 239000005715 Fructose Substances 0.000 description 7
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 7
- 230000005540 biological transmission Effects 0.000 description 7
- 210000003483 chromatin Anatomy 0.000 description 7
- 238000011534 incubation Methods 0.000 description 7
- 238000002347 injection Methods 0.000 description 7
- 239000007924 injection Substances 0.000 description 7
- 238000011068 loading method Methods 0.000 description 7
- 230000007935 neutral effect Effects 0.000 description 7
- 238000002203 pretreatment Methods 0.000 description 7
- 230000002829 reductive effect Effects 0.000 description 7
- 230000004044 response Effects 0.000 description 7
- 239000011734 sodium Substances 0.000 description 7
- 238000013519 translation Methods 0.000 description 7
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 6
- 239000004743 Polypropylene Substances 0.000 description 6
- 229940088710 antibiotic agent Drugs 0.000 description 6
- 230000009286 beneficial effect Effects 0.000 description 6
- 229920002301 cellulose acetate Polymers 0.000 description 6
- 239000012141 concentrate Substances 0.000 description 6
- 238000007796 conventional method Methods 0.000 description 6
- 230000005684 electric field Effects 0.000 description 6
- 238000011067 equilibration Methods 0.000 description 6
- 230000004720 fertilization Effects 0.000 description 6
- 230000005484 gravity Effects 0.000 description 6
- 238000012544 monitoring process Methods 0.000 description 6
- 238000001228 spectrum Methods 0.000 description 6
- 230000001360 synchronised effect Effects 0.000 description 6
- 238000012546 transfer Methods 0.000 description 6
- 238000011282 treatment Methods 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 229930003448 Vitamin K Natural products 0.000 description 5
- 238000009395 breeding Methods 0.000 description 5
- 230000001488 breeding effect Effects 0.000 description 5
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 5
- 238000013523 data management Methods 0.000 description 5
- 238000013461 design Methods 0.000 description 5
- 230000001627 detrimental effect Effects 0.000 description 5
- 239000000834 fixative Substances 0.000 description 5
- 239000007850 fluorescent dye Substances 0.000 description 5
- 230000010354 integration Effects 0.000 description 5
- 230000002503 metabolic effect Effects 0.000 description 5
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 5
- 230000002265 prevention Effects 0.000 description 5
- 230000035945 sensitivity Effects 0.000 description 5
- 238000002791 soaking Methods 0.000 description 5
- 241000894007 species Species 0.000 description 5
- 210000001215 vagina Anatomy 0.000 description 5
- 235000019168 vitamin K Nutrition 0.000 description 5
- 239000011712 vitamin K Substances 0.000 description 5
- 150000003721 vitamin K derivatives Chemical class 0.000 description 5
- 229940046010 vitamin k Drugs 0.000 description 5
- YASYEJJMZJALEJ-UHFFFAOYSA-N Citric acid monohydrate Chemical compound O.OC(=O)CC(O)(C(O)=O)CC(O)=O YASYEJJMZJALEJ-UHFFFAOYSA-N 0.000 description 4
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 229960002303 citric acid monohydrate Drugs 0.000 description 4
- 230000006835 compression Effects 0.000 description 4
- 238000007906 compression Methods 0.000 description 4
- 238000005094 computer simulation Methods 0.000 description 4
- 230000003750 conditioning effect Effects 0.000 description 4
- 235000013365 dairy product Nutrition 0.000 description 4
- 230000035558 fertility Effects 0.000 description 4
- 238000007710 freezing Methods 0.000 description 4
- 230000008014 freezing Effects 0.000 description 4
- 230000009477 glass transition Effects 0.000 description 4
- 239000012535 impurity Substances 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 description 4
- 235000019136 lipoic acid Nutrition 0.000 description 4
- 230000004807 localization Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 229940107700 pyruvic acid Drugs 0.000 description 4
- 239000002002 slurry Substances 0.000 description 4
- 230000008010 sperm capacitation Effects 0.000 description 4
- 229960002663 thioctic acid Drugs 0.000 description 4
- 230000000007 visual effect Effects 0.000 description 4
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 3
- 101001130128 Arabidopsis thaliana Leucoanthocyanidin dioxygenase Proteins 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 239000007995 HEPES buffer Substances 0.000 description 3
- OJMMVQQUTAEWLP-UHFFFAOYSA-N Lincomycin Natural products CN1CC(CCC)CC1C(=O)NC(C(C)O)C1C(O)C(O)C(O)C(SC)O1 OJMMVQQUTAEWLP-UHFFFAOYSA-N 0.000 description 3
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 3
- 239000004372 Polyvinyl alcohol Substances 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 102000019197 Superoxide Dismutase Human genes 0.000 description 3
- 108010012715 Superoxide dismutase Proteins 0.000 description 3
- 239000007983 Tris buffer Substances 0.000 description 3
- 230000001133 acceleration Effects 0.000 description 3
- 230000002411 adverse Effects 0.000 description 3
- 230000003139 buffering effect Effects 0.000 description 3
- 230000009087 cell motility Effects 0.000 description 3
- 229960004106 citric acid Drugs 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 230000000670 limiting effect Effects 0.000 description 3
- 229960005287 lincomycin Drugs 0.000 description 3
- OJMMVQQUTAEWLP-KIDUDLJLSA-N lincomycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@@H](C)O)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 OJMMVQQUTAEWLP-KIDUDLJLSA-N 0.000 description 3
- 238000012423 maintenance Methods 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 230000003204 osmotic effect Effects 0.000 description 3
- 230000036961 partial effect Effects 0.000 description 3
- 230000002093 peripheral effect Effects 0.000 description 3
- 229920001155 polypropylene Polymers 0.000 description 3
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 3
- 239000004810 polytetrafluoroethylene Substances 0.000 description 3
- 229920002451 polyvinyl alcohol Polymers 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 230000003595 spectral effect Effects 0.000 description 3
- 230000002459 sustained effect Effects 0.000 description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 2
- 101100366707 Arabidopsis thaliana SSL11 gene Proteins 0.000 description 2
- 101100366710 Arabidopsis thaliana SSL12 gene Proteins 0.000 description 2
- 101100096719 Arabidopsis thaliana SSL2 gene Proteins 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 239000004593 Epoxy Substances 0.000 description 2
- 241000283073 Equus caballus Species 0.000 description 2
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 2
- 229930182566 Gentamicin Natural products 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 101100179052 Hordeum vulgare BBBI gene Proteins 0.000 description 2
- 101100366560 Panax ginseng SS10 gene Proteins 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000004809 Teflon Substances 0.000 description 2
- 229920006362 Teflon® Polymers 0.000 description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 2
- 238000002679 ablation Methods 0.000 description 2
- 229940008201 allegra Drugs 0.000 description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 2
- 238000003975 animal breeding Methods 0.000 description 2
- 230000002547 anomalous effect Effects 0.000 description 2
- 230000003667 anti-reflective effect Effects 0.000 description 2
- 238000000429 assembly Methods 0.000 description 2
- 230000000712 assembly Effects 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 230000006399 behavior Effects 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000000356 contaminant Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 208000036552 dowling-degos disease 3 Diseases 0.000 description 2
- 201000010063 epididymitis Diseases 0.000 description 2
- 208000005244 familial abdominal 2 aortic aneurysm Diseases 0.000 description 2
- 208000002153 familial abdominal 3 aortic aneurysm Diseases 0.000 description 2
- RWTNPBWLLIMQHL-UHFFFAOYSA-N fexofenadine Chemical compound C1=CC(C(C)(C(O)=O)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 RWTNPBWLLIMQHL-UHFFFAOYSA-N 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 238000011010 flushing procedure Methods 0.000 description 2
- 239000005350 fused silica glass Substances 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- 230000002452 interceptive effect Effects 0.000 description 2
- 230000016507 interphase Effects 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 238000003064 k means clustering Methods 0.000 description 2
- 238000003475 lamination Methods 0.000 description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 description 2
- 210000001161 mammalian embryo Anatomy 0.000 description 2
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 2
- 229910052753 mercury Inorganic materials 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 238000000520 microinjection Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000003973 paint Substances 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- INAAIJLSXJJHOZ-UHFFFAOYSA-N pibenzimol Chemical compound C1CN(C)CCN1C1=CC=C(N=C(N2)C=3C=C4NC(=NC4=CC=3)C=3C=CC(O)=CC=3)C2=C1 INAAIJLSXJJHOZ-UHFFFAOYSA-N 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 210000003765 sex chromosome Anatomy 0.000 description 2
- UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 2
- 229960000268 spectinomycin Drugs 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 238000013024 troubleshooting Methods 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 229920002972 Acrylic fiber Polymers 0.000 description 1
- 101710087887 Alkyl hydroperoxide reductase C Proteins 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 101100064317 Arabidopsis thaliana DTX41 gene Proteins 0.000 description 1
- 101100398584 Arabidopsis thaliana TT10 gene Proteins 0.000 description 1
- 101100047785 Arabidopsis thaliana TT16 gene Proteins 0.000 description 1
- 101100048042 Arabidopsis thaliana UGT80B1 gene Proteins 0.000 description 1
- 101150108928 CCC1 gene Proteins 0.000 description 1
- 101150050425 CCC2 gene Proteins 0.000 description 1
- 241000272194 Ciconiiformes Species 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 239000012591 Dulbecco’s Phosphate Buffered Saline Substances 0.000 description 1
- 229920002449 FKM Polymers 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 101000955215 Homo sapiens Protein DDI1 homolog 1 Proteins 0.000 description 1
- 108091006905 Human Serum Albumin Proteins 0.000 description 1
- 102000008100 Human Serum Albumin Human genes 0.000 description 1
- 206010065042 Immune reconstitution inflammatory syndrome Diseases 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241000471154 Lithodesmium variabile Species 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 101100366562 Panax ginseng SS12 gene Proteins 0.000 description 1
- 101100366563 Panax ginseng SS13 gene Proteins 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 102100038994 Protein DDI1 homolog 1 Human genes 0.000 description 1
- 101000662518 Solanum tuberosum Sucrose synthase Proteins 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 229930194936 Tylosin Natural products 0.000 description 1
- 239000004182 Tylosin Substances 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 238000010923 batch production Methods 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 239000012888 bovine serum Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 150000001860 citric acid derivatives Chemical class 0.000 description 1
- 239000008119 colloidal silica Substances 0.000 description 1
- 238000010835 comparative analysis Methods 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 238000001152 differential interference contrast microscopy Methods 0.000 description 1
- 238000010252 digital analysis Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000001177 diphosphate Substances 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical class [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- BFMYDTVEBKDAKJ-UHFFFAOYSA-L disodium;(2',7'-dibromo-3',6'-dioxido-3-oxospiro[2-benzofuran-1,9'-xanthene]-4'-yl)mercury;hydrate Chemical compound O.[Na+].[Na+].O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C([O-])C([Hg])=C1OC1=C2C=C(Br)C([O-])=C1 BFMYDTVEBKDAKJ-UHFFFAOYSA-L 0.000 description 1
- 238000005315 distribution function Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 238000007786 electrostatic charging Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 210000000918 epididymis Anatomy 0.000 description 1
- 208000034199 familial abdominal 4 aortic aneurysm Diseases 0.000 description 1
- 210000005002 female reproductive tract Anatomy 0.000 description 1
- 239000012065 filter cake Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 150000002211 flavins Chemical class 0.000 description 1
- 239000005308 flint glass Substances 0.000 description 1
- 238000005188 flotation Methods 0.000 description 1
- 238000002421 fluorescence-activated droplet sorting Methods 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000009652 hydrodynamic focusing Methods 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000010365 information processing Effects 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 150000003893 lactate salts Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 238000000608 laser ablation Methods 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000000464 low-speed centrifugation Methods 0.000 description 1
- 238000003754 machining Methods 0.000 description 1
- 239000006249 magnetic particle Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 239000002991 molded plastic Substances 0.000 description 1
- 239000003068 molecular probe Substances 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 230000009022 nonlinear effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 229940056360 penicillin g Drugs 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 210000001938 protoplast Anatomy 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 150000004053 quinones Chemical class 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000012950 reanalysis Methods 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 229910052594 sapphire Inorganic materials 0.000 description 1
- 239000010980 sapphire Substances 0.000 description 1
- 238000013341 scale-up Methods 0.000 description 1
- 238000005204 segregation Methods 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 238000004513 sizing Methods 0.000 description 1
- 238000010583 slow cooling Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 231100000469 sperm hypomotility Toxicity 0.000 description 1
- 238000003879 sperm preservation Methods 0.000 description 1
- 230000009303 sperm storage Effects 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000007447 staining method Methods 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- OHKOGUYZJXTSFX-KZFFXBSXSA-N ticarcillin Chemical compound C=1([C@@H](C(O)=O)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)C=CSC=1 OHKOGUYZJXTSFX-KZFFXBSXSA-N 0.000 description 1
- 229960004659 ticarcillin Drugs 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 239000012780 transparent material Substances 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 238000007514 turning Methods 0.000 description 1
- 229960004059 tylosin Drugs 0.000 description 1
- WBPYTXDJUQJLPQ-VMXQISHHSA-N tylosin Chemical compound O([C@@H]1[C@@H](C)O[C@H]([C@@H]([C@H]1N(C)C)O)O[C@@H]1[C@@H](C)[C@H](O)CC(=O)O[C@@H]([C@H](/C=C(\C)/C=C/C(=O)[C@H](C)C[C@@H]1CC=O)CO[C@H]1[C@@H]([C@H](OC)[C@H](O)[C@@H](C)O1)OC)CC)[C@H]1C[C@@](C)(O)[C@@H](O)[C@H](C)O1 WBPYTXDJUQJLPQ-VMXQISHHSA-N 0.000 description 1
- 235000019375 tylosin Nutrition 0.000 description 1
- 238000013022 venting Methods 0.000 description 1
- 238000001429 visible spectrum Methods 0.000 description 1
Landscapes
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
Abstract
Une buse pour appareil de cytométrie à flux pour trier les cellules spermatiques dans un écoulement fluidique par teneur en chromosomes comprenant : a. un corps de buse ayant une partie d'entrée d'écoulement fluidique et une partie de sortie d'écoulement fluidique et une surface intérieure séparant les deux parties et le long de laquelle un écoulement fluidique est adapté pour s'écouler; b. la surface intérieure de la buse comportant une première, une deuxième et une troisième région axialement coniques pour accélérer progressivement la vitesse d'un écoulement fluidique dans une direction descendante vers la partie de sortie, au moins deux des régions ayant des formes transversales elliptiques orientées dans différentes directions pour exercer des forces de torsion sur un écoulement fluidique qui y circule, tendant à amener les cellules spermatiques dans l'écoulement dans un sens désiré.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US45873103P | 2003-03-28 | 2003-03-28 | |
US45860703P | 2003-03-28 | 2003-03-28 | |
US60/458,731 | 2003-03-28 | ||
US60/458,607 | 2003-03-28 | ||
CA2518882A CA2518882C (fr) | 2003-03-28 | 2004-03-29 | Dispositifs, procedes et processus permettant de trier des particules et d'obtenir du sperme animal produisant une progeniture de sexe donne |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2518882A Division CA2518882C (fr) | 2003-03-28 | 2004-03-29 | Dispositifs, procedes et processus permettant de trier des particules et d'obtenir du sperme animal produisant une progeniture de sexe donne |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2752247A1 true CA2752247A1 (fr) | 2004-10-14 |
CA2752247C CA2752247C (fr) | 2014-06-17 |
Family
ID=41494485
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2752312A Expired - Lifetime CA2752312C (fr) | 2003-03-28 | 2004-03-29 | Dispositifs, procedes et processus permettant de trier des particules et d'obtenir du sperme animal produisant une progeniture de sexe donne |
CA3002927A Expired - Lifetime CA3002927C (fr) | 2003-03-28 | 2004-03-29 | Dispositifs, procedes et processus permettant de trier des particules et d'obtenir du sperme animal produisant une progeniture de sexe donne |
CA2752218A Expired - Lifetime CA2752218C (fr) | 2003-03-28 | 2004-03-29 | Dispositifs, procedes et processus permettant de trier des particules et d'obtenir du sperme animal produisant une progeniture de sexe donne |
CA2752247A Expired - Lifetime CA2752247C (fr) | 2003-03-28 | 2004-03-29 | Dispositifs, procedes et processus permettant de trier des particules et d'obtenir du sperme animal produisant une progeniture de sexe donne |
CA2752244A Expired - Lifetime CA2752244C (fr) | 2003-03-28 | 2004-03-29 | Dispositifs, procedes et processus permettant de trier des particules et d'obtenir du sperme animal produisant une progeniture de sexe donne |
Family Applications Before (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2752312A Expired - Lifetime CA2752312C (fr) | 2003-03-28 | 2004-03-29 | Dispositifs, procedes et processus permettant de trier des particules et d'obtenir du sperme animal produisant une progeniture de sexe donne |
CA3002927A Expired - Lifetime CA3002927C (fr) | 2003-03-28 | 2004-03-29 | Dispositifs, procedes et processus permettant de trier des particules et d'obtenir du sperme animal produisant une progeniture de sexe donne |
CA2752218A Expired - Lifetime CA2752218C (fr) | 2003-03-28 | 2004-03-29 | Dispositifs, procedes et processus permettant de trier des particules et d'obtenir du sperme animal produisant une progeniture de sexe donne |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2752244A Expired - Lifetime CA2752244C (fr) | 2003-03-28 | 2004-03-29 | Dispositifs, procedes et processus permettant de trier des particules et d'obtenir du sperme animal produisant une progeniture de sexe donne |
Country Status (3)
Country | Link |
---|---|
CN (1) | CN101614731A (fr) |
CA (5) | CA2752312C (fr) |
ZA (1) | ZA200507151B (fr) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110456831A (zh) * | 2019-08-16 | 2019-11-15 | 南开大学 | 一种基于主动视觉的小鼠接触行为追踪平台 |
CN111458973A (zh) * | 2014-11-17 | 2020-07-28 | Asml荷兰有限公司 | 表膜框架附接设备 |
CN112638533A (zh) * | 2018-09-10 | 2021-04-09 | 索尼公司 | 微粒分类装置、细胞治疗剂制造装置、微粒分类方法和程序 |
CN114100706A (zh) * | 2021-10-18 | 2022-03-01 | 吉林大学 | 一种基于粒子漂移的粒子分选方法及系统 |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2306174B1 (fr) | 2003-03-28 | 2016-05-11 | Inguran, LLC | Buse de cytométrie en flux pour orienter des particles et procédé correspondant |
CN103013811A (zh) * | 2011-09-20 | 2013-04-03 | 北京富通华投资有限公司 | 精子分选仪 |
CN103540520B (zh) * | 2013-09-29 | 2015-03-04 | 大连金弘基种畜有限公司 | 椭锥螺纹喷嘴 |
CN103529036A (zh) * | 2013-10-08 | 2014-01-22 | 南京师范大学 | 一种鉴别杂交黄颡鱼幼鱼性别的方法 |
PL2997823T3 (pl) * | 2014-09-19 | 2018-06-29 | Instruments Utils De Laboratori Geniul, Sl | Procedura poprawy jakości spermy u ssaków |
US20180071981A1 (en) | 2015-03-31 | 2018-03-15 | The Regents Of The University Of California | System and method for tunable patterning and assembly of particles via acoustophoresis |
CN106342789B (zh) * | 2016-10-13 | 2022-07-15 | 深圳韦拓生物科技有限公司 | 一种细胞玻璃化冷冻处理设备及其处理方法 |
JP2020506699A (ja) * | 2017-01-31 | 2020-03-05 | ジェネア アイピー ホールディングス ピーティーワイ リミテッド | 生体試料を処理するための方法およびシステム |
CN110505918B (zh) * | 2017-02-13 | 2022-06-14 | 生物辐射实验室股份有限公司 | 用于形成乳状液阵列的系统、方法以及装置 |
CN107126215A (zh) * | 2017-06-15 | 2017-09-05 | 内蒙古智牧溯源技术开发有限公司 | 一种激光牲畜体尺测量装置 |
CN108041588A (zh) * | 2017-12-08 | 2018-05-18 | 冯纪敏 | 一种含有海藻糖的组合物及其应用 |
CN110339876B (zh) * | 2019-06-27 | 2021-04-30 | 昆明理工大学 | 一种基于液滴寄存的肿瘤细胞筛查微流控装置及筛查方法 |
CN110923139B (zh) * | 2019-11-29 | 2023-03-10 | 济宁医学院附属医院 | 一种人工辅助生殖精液自动核对及处理系统 |
CN111474293B (zh) * | 2020-04-27 | 2023-05-05 | 广东博创佳禾科技有限公司 | 一种青枯病菌溶液测定方法及测定系统 |
CN111895905B (zh) * | 2020-05-27 | 2022-04-19 | 中国计量大学 | 一种用于六方轴直线度检测系统的误差补偿方法 |
CN111624320B (zh) * | 2020-06-08 | 2022-11-25 | 深圳延浩科技有限公司 | 水质检测装置 |
CN112763462B (zh) * | 2020-12-31 | 2022-10-14 | 茶陵晶辉电子实业有限公司 | 一种基板玻璃透光率检测设备及基板玻璃制备工艺 |
CN112795476B (zh) * | 2021-04-15 | 2021-07-02 | 成都齐碳科技有限公司 | 纳米孔测序电路、测序方法及装置 |
CN114632726B (zh) * | 2022-03-10 | 2024-05-07 | 九州天禾(山东)智能科技有限公司 | 一种可实时监测防护的喷吹防堵结构 |
CN115245402B (zh) * | 2022-09-21 | 2022-12-09 | 山东四方新域农牧科技股份有限公司 | 一种家兔集约化养殖用自动受精设备 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2217342A (en) * | 1938-05-19 | 1940-10-08 | Aaron G Ladrach | Time or speed controlled delayed action relay for strip material classifiers |
US4325483A (en) * | 1979-08-20 | 1982-04-20 | Ortho Diagnostics, Inc. | Method for detecting and controlling flow rates of the droplet forming stream of an electrostatic particle sorting apparatus |
US5199576A (en) * | 1991-04-05 | 1993-04-06 | University Of Rochester | System for flexibly sorting particles |
JP3079932B2 (ja) * | 1994-12-28 | 2000-08-21 | 株式会社佐竹製作所 | 穀粒色彩選別装置 |
US6149867A (en) * | 1997-12-31 | 2000-11-21 | Xy, Inc. | Sheath fluids and collection systems for sex-specific cytometer sorting of sperm |
KR20010041113A (ko) * | 1998-02-20 | 2001-05-15 | 헤릭호프, 리사 | 분류용 플로우 사이토미터의 진동시스템 |
JP2005535346A (ja) * | 2002-08-15 | 2005-11-24 | エックスワイ,インコーポレイテッド | 高分解能フローサイトメーター |
-
2004
- 2004-03-29 CA CA2752312A patent/CA2752312C/fr not_active Expired - Lifetime
- 2004-03-29 CA CA3002927A patent/CA3002927C/fr not_active Expired - Lifetime
- 2004-03-29 CA CA2752218A patent/CA2752218C/fr not_active Expired - Lifetime
- 2004-03-29 CA CA2752247A patent/CA2752247C/fr not_active Expired - Lifetime
- 2004-03-29 CA CA2752244A patent/CA2752244C/fr not_active Expired - Lifetime
- 2004-03-29 CN CN200910146867A patent/CN101614731A/zh active Pending
-
2005
- 2005-09-06 ZA ZA200507151A patent/ZA200507151B/xx unknown
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111458973A (zh) * | 2014-11-17 | 2020-07-28 | Asml荷兰有限公司 | 表膜框架附接设备 |
CN111458973B (zh) * | 2014-11-17 | 2024-02-09 | Asml荷兰有限公司 | 表膜框架附接设备 |
CN112638533A (zh) * | 2018-09-10 | 2021-04-09 | 索尼公司 | 微粒分类装置、细胞治疗剂制造装置、微粒分类方法和程序 |
CN112638533B (zh) * | 2018-09-10 | 2023-08-22 | 索尼公司 | 微粒分类装置、细胞治疗剂制造装置、微粒分类方法和程序 |
CN110456831A (zh) * | 2019-08-16 | 2019-11-15 | 南开大学 | 一种基于主动视觉的小鼠接触行为追踪平台 |
CN110456831B (zh) * | 2019-08-16 | 2022-06-14 | 南开大学 | 一种基于主动视觉的小鼠接触行为追踪平台 |
CN114100706A (zh) * | 2021-10-18 | 2022-03-01 | 吉林大学 | 一种基于粒子漂移的粒子分选方法及系统 |
CN114100706B (zh) * | 2021-10-18 | 2022-08-19 | 吉林大学 | 一种基于粒子漂移的粒子分选方法及系统 |
Also Published As
Publication number | Publication date |
---|---|
CA3002927C (fr) | 2021-05-04 |
CA2752312A1 (fr) | 2004-10-14 |
CN101614731A (zh) | 2009-12-30 |
CA2752312C (fr) | 2018-06-19 |
CA2752244A1 (fr) | 2004-10-14 |
CA2752218A1 (fr) | 2004-10-14 |
CA2752218C (fr) | 2015-12-08 |
CA2752244C (fr) | 2014-12-16 |
ZA200507151B (en) | 2009-11-25 |
CA3002927A1 (fr) | 2004-10-14 |
CA2752247C (fr) | 2014-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9377390B2 (en) | Apparatus, methods and processes for sorting particles and for providing sex-sorted animal sperm | |
CA2752247C (fr) | Dispositifs, procedes et processus permettant de trier des particules et d'obtenir du sperme animal produisant une progeniture de sexe donne | |
AU2012227165B2 (en) | System and apparatus for sorting particles | |
AU2012200712B2 (en) | "A process for evaluating staining conditions of cells for sorting" | |
AU2012200713B2 (en) | "Methods for sorting particles" |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKEX | Expiry |
Effective date: 20240402 |